Search

Short-term effects of intravitreal bevacizumab on the cornea

Bevacizumab has been extensively used to treat macula oedema and neovascularisation of the retina and it has also been useful in the management of corneal neovascular diseases. This prospective study aimed to provide more information on the effect bevacizumab may...

High-fluence collagen cross-linking

The authors treat seven eyes with progressive keratoconus with a high energy (18mW) for five minutes delivering a total energy similar to that suggested by the original Dresden protocol (3mW for 30mins). All eyes had a thickness >400µm following epithelial...

Customised corneal crosslinking with supplemental oxygen

In this prospective interventional case series, the authors investigate using supplemental oxygen delivery during epithelium-on corneal crosslinking (CXL) with specially designed oxygen delivery goggles. Twenty-seven eyes of 24 patients underwent epi-on CXL with Riboflavin and Ultraviolet-A irradiation. At six months...

Effect of long-term RGP-CL wear on keratoconus progression

This is a retrospective study between April and December 2017, of 22 rigid gas-permeable contact lens (RGP-CL) patients (31 eyes) and 15 non-CL patients (20 eyes) who fulfilled the criteria of: 1) >3 years follow-up and 2) Scheimpflug-based corneal imaging...

Outcomes for IRS implantation for keratoconus

The authors report visual and topographic outcomes of intracorneal ring segment (ICRS) implantation alone or in combination with corneal cross linking (CXL) and long-term results in halting keratoconus in paediatric patients. This study was a retrospective design including 19 patients...

Long-term outcomes of deep anterior lamellar versus penetrating keratoplasty for keratoconus

This is a retrospective consecutive and comparative case series of keratoplasties (228 deep anterior lamellar keratoplasties (DALKs) and 274 penetrating keratoplasties (PKs)) in a single centre by one surgeon in France, between 1993 and 2021. Graft survival was 96.7% at...

Paediatric ophthalmology five-year results of atropine 0.01% efficacy in the myopia control in a European population

This a prospective, randomised and longitudinal study from Madrid, Spain in 361 eyes from 361 children randomised into the control group (177 eyes with no treatment) and the treatment group (184 eyes with 0.01% atropine drops once daily). Complete eye...